Patent details

EP3791860 Title: STABLE LIQUID GONADOTROPIN FORMULATION

Basic Information

Publication number:
EP3791860
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP202027587
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
STABLE LIQUID GONADOTROPIN FORMULATION
French Title of Invention:
FORMULATION LIQUIDE STABLE DE GONADOTROPHINES
German Title of Invention:
STABILE FLÜSSIGE GONADOTROPIN-FORMULIERUNG
SPC Number:

Dates

Filing date:
24/02/2017
Grant date:
11/10/2023
EP Publication Date:
17/03/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/10/2023
EP B1 Publication Date:
11/10/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/02/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/10/2023
 
 

Name:
Ferring B.V.
Address:
Polaris Avenue 144, 2132 JX Hoofddorp, Netherlands (NL)

Agent

Name:
ARONOVA S.A.
From:
28/11/2023
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
Højer-Pedersen, Charlotte
Address:
Denmark (DK)

2

Name:
Sjögren, Helen Ulrika
Address:
Sweden (SE)

Priority

Priority Number:
201603280
Priority Date:
24/02/2016
Priority Country:
United Kingdom (GB)

Classification

IPC classification:
A61K 9/00; A61K 9/08; A61K 47/18; A61P 15/08; A61K 38/24; A61K 47/20;

Publication

European Patent Bulletin

Issue number:
202341
Publication date:
11/10/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
10
Annual Fee Amount:
131 Euro
Expected Payer:
Last Annual Fee Payment Date:
24/02/2025
Last Annual Fee Paid Number:
9
Last Annual Fee Paid Amount:
115 Euro
Payer:
IPAN GMBH
Filing date Document type Number of pages
28/11/2023 Power Of Attorney 1
29/11/2023 Outgoing Correspondence 1